SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-176075
Filing Date
2007-08-09
Accepted
2007-08-08 20:56:32
Documents
4
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR QUARTERLY PERIOD ENDED JUNE 30, 2007 d10q.htm 10-Q 485081
2 CERTIFICATION OF PEO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 8969
3 CERTIFICATION OF PFO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 9171
4 CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 4454
  Complete submission text file 0001193125-07-176075.txt   509266
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 071037527
SIC: 2834 Pharmaceutical Preparations